Autoantibodies against Endothelin 1 Type A Receptor Are Strong Predictors of Digital Ulcers in Systemic Sclerosis.

CONCLUSION: Anti-ETAR autoantibodies can be used together with the presence of current or past DU to identify patients with SSc who are at risk for the development of subsequent DU. These autoantibodies may allow for earlier management and therapeutic intervention. PMID: 26233500 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/26233500?dopt=Abstract

Source: J Rheumatol - August 1, 2015 Category: Rheumatology Authors: Avouac J, Riemekasten G, Meune C, Ruiz B, Kahan A, Allanore Y Tags: J Rheumatol Source Type: research

More News: Rheumatology | Scleroderma